Studies have shown that in patients with cirrhosis albumin is subjected to posttranscriptional modifications leading to oxidized forms of albumin with impairment of its non-oncotic biological properties and thus leading to decreased “effective” albumin concentration [60]. The gene discussed is ALB; the disease is Cirrhosis.